Literature DB >> 1284062

Cytomegalovirus- and interferon-related effects on human endothelial cells. Cytomegalovirus infection reduces upregulation of HLA class II antigen expression after treatment with interferon-gamma.

M Scholz1, A Hamann, R A Blaheta, M K Auth, A Encke, B H Markus.   

Abstract

Cultured human umbilical vein endothelial cells (HUVEs) were infected with human cytomegalovirus (HCMV) strain AD169. Up to 50% HUVEs proved to be positive for HCMV early nuclear antigens 24 hours after inoculation with virus. Following infection kinetics of surface expression of HLA class I and II, intercellular adhesion molecule (ICAM-1) and endothelial lymphocyte adhesion molecule (ELAM-1) on HUVEs were investigated by means of flow cytometry. A slight increase in HLA class I expression was observed, whereas expression of HLA class II (DR, DP, DQ) antigens was not induced by infection with HCMV. Furthermore, when compared with uninfected cells treated with interferon-gamma (IFN-gamma), reduced enhancement of HLA-DR expression was conspicuous in HCMV-infected cells treated with IFN-gamma. There is evidence that only a portion of HUVE is affected in its ability to upregulate HLA class II antigens. While expression of ICAM-1 was found to be enhanced between 8 and 20 hours after infection with a maximum at 12 hours after infection, no modulation of ELAM-1 was seen.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1284062     DOI: 10.1016/0198-8859(92)90004-7

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  15 in total

1.  Selective migration of highly differentiated primed T cells, defined by low expression of CD45RB, across human umbilical vein endothelial cells: effects of viral infection on transmigration.

Authors:  N J Borthwick; A N Akbar; L P MacCormac; M Lowdell; J L Craigen; I Hassan; J E Grundy; M Salmon; K L Yong
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

Review 2.  Prophylaxis of cytomegalovirus disease in high-risk patients.

Authors:  M Scholz; J Cinatl; H W Doerr
Journal:  Infection       Date:  1997 Sep-Oct       Impact factor: 3.553

3.  Modulation of major histocompatibility class II protein expression by varicella-zoster virus.

Authors:  A Abendroth; B Slobedman; E Lee; E Mellins; M Wallace; A M Arvin
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Early E-selectin, VCAM-1, ICAM-1, and late major histocompatibility complex antigen induction on human endothelial cells by flavivirus and comodulation of adhesion molecule expression by immune cytokines.

Authors:  J Shen; S S T-To; L Schrieber; N J King
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

Review 5.  Modulation of major histocompatibility complex antigen expression by viral infection.

Authors:  C R Rinaldo
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

6.  The role of interferon beta in human cytomegalovirus-mediated inhibition of HLA DR induction on endothelial cells.

Authors:  D D Sedmak; S Chaiwiriyakul; D A Knight; W J Waldmann
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

7.  Double fluorescence analysis of human cytomegalovirus (HCMV) infected human fibroblast cultures by flow cytometry: increase of class I MHC expression on uninfected cells and decrease on infected cells.

Authors:  M Steinmassl; K Hamprecht
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

8.  Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cells.

Authors:  D D Sedmak; A M Guglielmo; D A Knight; D J Birmingham; E H Huang; W J Waldman
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

Review 9.  Multifaceted evasion of the interferon response by cytomegalovirus.

Authors:  Emily E Marshall; Adam P Geballe
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

10.  Cytokine-mediated induction of endothelial adhesion molecule and histocompatibility leukocyte antigen expression by cytomegalovirus-activated T cells.

Authors:  W J Waldman; D A Knight
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.